Harold H. Shlevin

CIK: 0001557082

Transaction Breakdown

Open Market Buys (P)1 (3.4%)

High conviction signal

Open Market Sales (S)14 (48.3%)

Position reduction

Option Exercises (M)12 (41.4%)

Derivative conversions

Awards (A)2 (6.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GALT

GALECTIN THERAPEUTICS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (29 total)

GALT
GALECTIN THERAPEUTICS INC
Jun 29, 2026
Exercise(M)
Direct
22.3K shares at avg. $1.23$27K
GALT
GALECTIN THERAPEUTICS INC
Jun 29, 2026
Sale(S)
Direct
22.3K shares at avg. $5.04$112K
GALT
GALECTIN THERAPEUTICS INC
Jun 26, 2026
Sale(S)
Direct
7.7K shares at avg. $5.00$39K
GALT
GALECTIN THERAPEUTICS INC
Jun 26, 2026
Exercise(M)
Direct
7.7K shares at avg. $1.23$10K
GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Stock option (right to buy)
Direct
60K shares-
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Exercise(M)
Direct
20K shares at avg. $1.98$40K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Sale(S)
Direct
19.8K shares at avg. $7.04$139K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Sale(S)
Direct
4.7K shares at avg. $7.04$33K
GALT
GALECTIN THERAPEUTICS INC
Dec 15, 2025
Sale(S)
Direct
8.4K shares at avg. $6.30$53K
GALT
GALECTIN THERAPEUTICS INC
Dec 15, 2025
Exercise(M)
Direct
8.4K shares at avg. $4.16$35K
GALT
GALECTIN THERAPEUTICS INC
Dec 12, 2025
Sale(S)
Direct
19.8K shares at avg. $6.27$124K
GALT
GALECTIN THERAPEUTICS INC
Dec 12, 2025
Exercise(M)
Direct
19.8K shares at avg. $4.16$82K
GALT
GALECTIN THERAPEUTICS INC
Dec 9, 2025
Sale(S)
Direct
16.8K shares at avg. $6.27$105K
GALT
GALECTIN THERAPEUTICS INC
Dec 9, 2025
Exercise(M)
Direct
16.8K shares at avg. $4.16$70K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Exercise(M)
Direct
25K shares at avg. $1.72$43K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Sale(S)
Direct
25K shares at avg. $5.95$149K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Exercise(M)
Direct
35K shares at avg. $2.11$74K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Sale(S)
Direct
35K shares at avg. $6.02$211K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Exercise(M)
Direct
35K shares at avg. $2.86$100K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Sale(S)
Direct
20K shares at avg. $6.00$120K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Sale(S)
Direct
4K shares at avg. $6.00$24K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Exercise(M)
Direct
20K shares at avg. $1.11$22K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Sale(S)
Direct
35K shares at avg. $5.95$208K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Exercise(M)
Direct
20K shares at avg. $2.11$42K
GALT
GALECTIN THERAPEUTICS INC
Dec 8, 2025
Sale(S)
Direct
20K shares at avg. $5.96$119K

		Type	Shares	Price		Ownership
Jun 29, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	22,268	$1.23	$27,390	Direct
Jun 29, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	22,268	$5.04	$112,231	Direct
Jun 26, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	7,732	$5.00	$38,660	Direct
Jun 26, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	7,732	$1.23	$9,510	Direct
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Stock option (right to buy)	60,000	-	-	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	20,000	$1.98	$39,600	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	19,793	$7.04	$139,303	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	4,706	$7.04	$33,121	Direct
Dec 15, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	8,417	$6.30	$53,027	Direct
Dec 15, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	8,417	$4.16	$35,015	Direct
Dec 12, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	19,793	$6.27	$124,181	Direct
Dec 12, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	19,793	$4.16	$82,339	Direct
Dec 9, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	16,790	$6.27	$105,206	Direct
Dec 9, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	16,790	$4.16	$69,846	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	25,000	$1.72	$43,000	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	25,000	$5.95	$148,650	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	35,000	$2.11	$73,850	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	35,000	$6.02	$210,665	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	35,000	$2.86	$100,100	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	20,000	$6.00	$120,040	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	4,000	$6.00	$24,020	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	20,000	$1.11	$22,200	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	35,000	$5.95	$208,250	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	20,000	$2.11	$42,200	Direct
Dec 8, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	20,000	$5.96	$119,240	Direct

1-25 of 29 transactions

About Shlevin Harold H.

Shlevin Harold H. (SEC CIK 0001557082) files insider reports with the SEC as Director of GALECTIN THERAPEUTICS INC (GALT).

Signal8 holds 7 ownership filings by Shlevin Harold H., all Form 4s, filed between Dec 31, 2024 and Jun 30, 2026. Those filings report 29 transactions, from Dec 30, 2024 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Shlevin Harold H.'s filings is in NORCROSS, GA.

Recent filings by Shlevin Harold H.

Jun 29, 2026: Option exercise of GALT shares (Form 4, code M).
Jun 29, 2026: Open-market sale of GALT shares (Form 4, code S).
Jun 26, 2026: Open-market sale of GALT shares (Form 4, code S).
Jun 26, 2026: Option exercise of GALT shares (Form 4, code M).
Jan 16, 2026: Grant or award of GALT derivative securities (Form 4, code A).

Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)

Uihlein Richard E, Director
Jamil Khurram, Chief Medical Officer
Brem Henry, Director
ELDRED KARY, Director
LEWIS JOEL, President and CEO
CARSON BENJAMIN SR, Director

How to read Form 4 transaction codes